Clinical Trial Update: Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA) [NA]

View source ↗

Summary

The LUTEGA trial evaluated the long-term effects of lutein/zeaxanthin and omega-3 supplementation on optical density in patients with age-related macular degene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lutein/Zeaxanthin supplementation (lutein and zeaxanthin)
• Omega-3 fatty acid supplementation (Omega-3 fatty acids)

Snippet

Sponsor: University of Jena | Conditions: Age Related Maculopathy | NA | Status: COMPLETED